CCL5 and breast carcinoma: MSCs have been associated with tumor growth and metastatic potential of breast cancer cells via activating EMT in cancer cells [7,23], increasing tumor-initiating cell populations [24], increasing vascular endothelial factor (VEGF) signaling [25,26], and inducing the secretion of the chemokine CCL5 [6].